Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Current Hematologic Malignancy Reports|March 18, 2016
Management of Patients with MYC-Altered LymphomasDaniel J LandsburgCurrent Hematologic Malignancy Reports|August 17, 2018
Small-Molecule Inhibitors for the Treatment of Diffuse Large B Cell LymphomaJoanna Rhodes, Daniel J LandsburgClinical Lymphoma, Myeloma & Leukemia|June 25, 2020
Real World Outcomes in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Receiving Palliative Intent TherapiesEmily C Ayers, David Margolis, Daniel J LandsburgJCO Oncology Practice|May 18, 2023
Central Line-Associated Bloodstream Infection in Patients With Hematologic Malignancy Receiving Parenteral NutritionHeather Lazarow, Charlene Compher, Matthew J Ziegler, et al.Virology|February 1, 2005
Contribution of cysteine residues to the structure and function of herpes simplex virus gH/gLTina M Cairns, Daniel J Landsburg, J Charles Whitbeck, et al.British Journal of Haematology|April 26, 2014
'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patientsDaniel J Landsburg, Sunita D Nasta, Jakub Svoboda, et al.Clinical Lymphoma, Myeloma & Leukemia|May 5, 2019
Nutrition-Related Outcomes for Autologous Stem Cell Transplantation PatientsHeather Lazarow, Michele Nicolo, Charlene Compher, et al.Leukemia & Lymphoma|December 27, 2019
Management and outcomes of sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman Disease)Esin C Namoglu, Mitchell E Hughes, John P Plastaras, et al.Journal of Virology|June 28, 2003
Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interfaceSarah A Connolly, Daniel J Landsburg, Andrea Carfi, et al.Pageof 8